German pharmaceutical company Boehringer Ingelheim said Wednesday its oral blood-thinning drug Pradaxa for the prevention of stroke and embolism in patients with irregular heart beat has been approved in Canada.
Boehringer Ingelheim's Pradaxa approved in Canada